Overview
HVAX Technologies Limited specializes in providing turnkey cleanroom and controlled environment infrastructure solutions aimed at the pharmaceutical, healthcare, hospital, and biotech sectors.
The company is expanding into the healthcare infrastructure segment with a proposed acquisition of Krew Instruments, which aligns with HVAX's vision to diversify its portfolio.
HVAX shows strong growth momentum with a current order book of INR350 crores and a pipeline worth INR650 crores, showcasing its ability to convert opportunities into financial successes.
Their strategy involves expanding operations through strategic partnerships and acquisitions, enhancing capabilities and establishing footholds in the healthcare market.
HVAX anticipates a revenue growth of 35% year-on-year, driven by strategic expansions, operational efficiency, and a robust order pipeline in pharmaceuticals and emerging sectors.
- Sector
Engineering
- Industry
Engineering - Turnkey Services
- Market Cap
197 Cr
- Volatility
Low Risk
- P/E Ratio
15.4
- Industry P/E
22.7
- PEG Ratio
0.4
- P/B Ratio
2.7
- 52W High
1,029.30
- 52W Low
560.00
Financial Ratios
Sales CAGR
- 1Y
- 23.54%
- 3Y
- 24.28%
- 5Y
- 22.81%
- 10Y
- —
Profit CAGR
- 1Y
- 29.58%
- 3Y
- 38.23%
- 5Y
- 42.11%
- 10Y
- —
ROE
- TTM
- 15.78%
- 3Y
- 20.60%
- 5Y
- 22.93%
- 10Y
- —
ROCE
- TTM
- 19.74%
- 3Y
- 29.46%
- 5Y
- 31.29%
- 10Y
- —
Peers
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
37.41 | 258 Cr | 9.95 | 4.83 | 0.80 | 11.91 | 14.44 | 6.04 | |
366.00 | 229 Cr | 0.29 | 3.89 | 0.00 | 14.58 | 18.47 | 10.18 | |
155.00 | 219 Cr | 12.13 | 2.02 | 0.00 | 13.61 | 20.09 | 5.61 | |
89.99 | 209 Cr | 8.72 | 1.71 | 0.00 | 17.88 | 17.36 | 9.30 | |
707.95 | 197 Cr | 15.42 | 2.73 | 0.00 | 15.78 | 19.74 | 10.88 | |
117.26 | 174 Cr | 10.94 | 1.31 | 1.71 | 10.84 | 11.34 | 7.21 | |
126.50 | 146 Cr | 12.38 | 2.95 | 0.00 | 22.51 | 22.55 | 11.05 |
Price Chart Comparison
Financial Statements
AI Powered Summary
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Ask AI
Standalone Half Yearly Results (in ₹ Crores)
Standalone Profit Loss (in ₹ Crores)
Standalone Balance Sheet (in ₹ Crores)
Standalone Cash Flows (in ₹ Crores)
Documents
Investor Presentation
Q4 FY25
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
Frequently Asked Questions about HVAX Technologies Ltd
HVAX Technologies Ltd (HVAX) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
HVAX Technologies Limited specializes in providing turnkey cleanroom and controlled environment infrastructure solutions aimed at the pharmaceutical, healthcare, hospital, and biotech sectors. The company is expanding into the healthcare infrastructure segment with a proposed acquisition of Krew Instruments, which aligns with HVAX's vision to diversify its portfolio. HVAX shows strong growth momentum with a current order book of INR350 crores and a pipeline worth INR650 crores, showcasing its ability to convert opportunities into financial successes. Their strategy involves expanding operations through strategic partnerships and acquisitions, enhancing capabilities and establishing footholds in the healthcare market. HVAX anticipates a revenue growth of 35% year-on-year, driven by strategic expansions, operational efficiency, and a robust order pipeline in pharmaceuticals and emerging sectors.
Over the past 52 weeks, HVAX Technologies Ltd has traded between a low of ₹0.00 and a high of ₹1,029.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
HVAX Technologies Ltd has a market capitalization of approximately 196.59. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
HVAX Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.42 and operates in the Engineering sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 196.59 Cr, HVAX Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
HVAX Technologies Ltd operates in the Engineering sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of HVAX Technologies Ltd is 15.42. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
